Manning Meredith 4
4 · SOLENO THERAPEUTICS INC · Filed Jul 19, 2024
Insider Transaction Report
Form 4
Manning Meredith
Chief Commercial Officer
Transactions
- Award
Common Stock
2024-07-17+40,000→ 40,000 total
Footnotes (2)
- [F1]These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 50% of the RSUs subject to the award shall vest on the NDA Approval Date and 50% of the RSUs subject to the award shall vest on the one year anniversary of the NDA Approval Date, subject to the Reporting Person continuing as a service provider through each such date.
- [F2]Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.